Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ZVRA is expected to report earnings to rise 140.00% to -2 cents per share on March 11
Q4'25
Est.
$-0.02
Q3'25
Beat
by $0.02
Q2'25
Missed
by $2.25
Q1'25
Beat
by $0.18
Q4'24
Missed
by $0.27
The last earnings report on November 05 showed earnings per share of 0 cents, beating the estimate of -2 cents. With 1.23M shares outstanding, the current market capitalization sits at 519.63M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ZVRA showed earnings on November 05, 2025. You can read more about the earnings report here.